Zosano Pharma Corp Operating Lease Cost
Zosano Pharma Corp reported Operating Lease Cost of $439.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2022-05-13
- Zosano Pharma Corp operating lease, cost for the quarter ending 2022-03-31 was $439.00K, a 0.00% change year-over-year.
- Zosano Pharma Corp operating lease, cost for the quarter ending 2021-12-31 was $439.00K, a 0.23% decline year-over-year.
- Zosano Pharma Corp operating lease, cost for the quarter ending 2021-09-30 was $439.00K, a 4.03% increase year-over-year.
- Zosano Pharma Corp operating lease, cost for the quarter ending 2021-06-30 was $439.00K, a 4.03% increase year-over-year.
- Zosano Pharma Corp operating lease, cost for fiscal 2021 was $1.76M, a 2.93% increase from fiscal 2020.
- Zosano Pharma Corp operating lease, cost for fiscal 2020 was $1.71M, a 2.09% increase from fiscal 2019.
- Zosano Pharma Corp operating lease, cost for fiscal 2019 was $1.67M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2022-03-31 | $439.00K 10-Q · filed 2022-05-13 | $878.00K derived: sum of 2 quarters · filed 2022-05-13 | $1.32M derived: sum of 3 quarters · filed 2022-05-13 | $1.76M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | $439.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $878.00K derived: sum of 2 quarters · filed 2022-03-17 | $1.32M derived: sum of 3 quarters · filed 2022-03-17 | $1.76M 10-K · filed 2022-03-17 |
| 2021-09-30 | $439.00K 10-Q · filed 2021-11-10 | $878.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.32M 10-Q · filed 2021-11-10 | $1.76M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | $439.00K 10-Q · filed 2021-08-10 | $878.00K 10-Q · filed 2021-08-10 | $1.32M derived: sum of 3 quarters · filed 2022-05-13 | $1.74M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | $439.00K 10-Q · filed 2022-05-13 | $879.00K derived: sum of 2 quarters · filed 2022-05-13 | $1.30M derived: sum of 3 quarters · filed 2022-05-13 | $1.72M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $440.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $862.00K derived: sum of 2 quarters · filed 2022-03-17 | $1.28M derived: sum of 3 quarters · filed 2022-03-17 | $1.71M 10-K · filed 2022-03-17 |
| 2020-09-30 | $422.00K 10-Q · filed 2021-11-10 | $844.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.27M 10-Q · filed 2021-11-10 | $1.69M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $422.00K 10-Q · filed 2021-08-10 | $844.00K 10-Q · filed 2021-08-10 | $1.26M derived: sum of 3 quarters · filed 2021-08-10 | $1.69M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $422.00K 10-Q · filed 2021-05-12 | $843.00K derived: sum of 2 quarters · filed 2021-05-12 | $1.26M derived: sum of 3 quarters · filed 2021-05-12 | $1.68M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $421.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $843.00K derived: sum of 2 quarters · filed 2021-03-11 | $1.25M derived: sum of 3 quarters · filed 2021-03-11 | $1.67M 10-K · filed 2021-03-11 |
| 2019-09-30 | $422.00K 10-Q · filed 2020-11-13 | $832.00K derived: sum of 2 quarters · filed 2020-11-13 | $1.25M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $410.00K 10-Q · filed 2020-08-06 | $820.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $410.00K 10-Q · filed 2020-05-14 |